Biosynex Pharma Benelux SRL
7.2 FTEBiosynex Pharma Benelux reported total assets of €2.94m at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jun 2026), with 7.2 full-time equivalents.
By total assets for 2025, Biosynex Pharma Benelux ranks in the top half of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Biosynex Pharma Benelux shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -56 % Total assets -59 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biosynex Pharma Benelux's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jun 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 17 Jul 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
Biosynex Pharma Benelux's financial analysis
- Solvency57.8%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biosynex Pharma Benelux
Biosynex Pharma Benelux's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0787.324.947
- VAT number
- BE0787324947
- Peppol
- Registered · 0208:0787324947 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Jun 2022
- Registered office
- 1210 Saint-Josse-ten-Noode
- Size
- Micro · 7.2 FTE
- Latest accounts
- 2025 · filed on 22 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Biosynex Pharma Benelux (SRL) has been based in Saint-Josse-ten-Noode since 2022, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 678,477 € and equity of €1.70m; its revenue is not published. With 7.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 57.8%, above the median of its sector (32.3%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Biosynex Pharma Benelux
Companies in the same business, of comparable size and area, outside its group.
- GUANG JI Pharmaceutical Belgium sa Business and other management consultancy activities Ottignies-Louvain-la-Neuve · balance sheet 32,994 €
- RNA Pioneering Business and other management consultancy activities Ghent · balance sheet €5.63m
- Verachtert Digital Manufacture of medical and dental instruments and supplies Antwerp · balance sheet €1.08m
- De Dommel Business and other management consultancy activities Waasmunster · balance sheet 730,988 €
- Advanz Pharma Belgium Wholesale of pharmaceutical and medical goods Saint-Josse-ten-Noode · balance sheet 365,371 €
- XMED iQ France BeNeLux Wholesale of pharmaceutical and medical goods Brussels · balance sheet 653,917 €
- Brucare Wholesale of pharmaceutical and medical goods Overijse · balance sheet 903,825 €
- Meda Bright Wholesale of pharmaceutical and medical goods Brussels · balance sheet 469,972 €
Frequently asked questions about Biosynex Pharma Benelux
What is the revenue of Biosynex Pharma Benelux?
Biosynex Pharma Benelux files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Biosynex Pharma Benelux?
In Belgium, the VAT number is the company number prefixed with BE: BE0787324947 for Biosynex Pharma Benelux, if the company is VAT-registered. Its company number (CBE) is 0787.324.947.
Where is the registered office of Biosynex Pharma Benelux?
According to the CBE register, the registered office of Biosynex Pharma Benelux is in 1210 Saint-Josse-ten-Noode.
What is the equity of Biosynex Pharma Benelux?
At the close of the 2025 financial year, the equity of Biosynex Pharma Benelux amounts to 1,698,117 €, a solvency of 57.8% of total assets.
How many people work at Biosynex Pharma Benelux?
7.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Biosynex Pharma Benelux?
The register lists 2 active mandates at Biosynex Pharma Benelux. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Biosynex Pharma Benelux within its sector?
By total assets for 2025, Biosynex Pharma Benelux ranks in the top half of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year.
The full file of Biosynex Pharma Benelux
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →